Scimago Lab
powered by Scopus
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST


Medical Science Monitor Basic Research


eISSN: 1643-3750

Get your full text copy in PDF

An assessment of downward trends in neurodevelopmental disorders in the United States following removal of thimerosal from childhood vaccines.

David A. Geier, Mark R. Geier

Med Sci Monit 2006; 12(6): CR231-239

ID: 451248

Background: The US is in the midst of an epidemic of neurodevelopmentaldisorders (NDs). Thimerosal is an ethylmercury-containing compound added to some childhood vaccines.Several previous epidemiological studies conducted in the US have associated Thimerosal-containing vaccine(TCV) administration with NDs. Material/Methods: An ecological study was undertaken to evaluate NDs reportedto the Vaccine Adverse Event Reporting System (VAERS) from 1991 through 2004 by date of receipt and bydate of vaccine administration. The NDs examined included autism, mental retardation, and speech disorders.Statistical trend analysis was employed to evaluate the effects of removal of Thimerosal on the proportionof NDs reported to VAERS. Results: There was a peak in the proportion of ND reports received by VAERSin 2001-2002 and in the proportion of ND reports by date of vaccine administration in 1998. There weresignificant reductions in the proportion of NDs reported to VAERS as Thimerosal was begun to be removedfrom childhood vaccines in the US from mid-1999 onwards. Conclusions: The present study provides thefirst epidemiological evidence showing that as Thimerosal was removed from childhood vaccines, the numberof NDs has decreased in the US. The analysis techniques utilized attempted to minimize chance or bias/confounding.Additional research should be conducted to further evaluate the relationship between TCVs and NDs. Thisis especially true because the handling of vaccine safety data from the National Immunization Programof the CDC has been called into question by the Institute of Medicine of the National Academy of Sciencesin 2005.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree